AU Patent

AU2024348342A1 — Method of treating post-traumatic stress disorder

Assigned to Bionomics Ltd · Expires 2026-04-30 · 0y expired

What this patent protects

This disclosure provides therapeutic methods involving administration of BNC210 to a subject in an amount effective to reduce or eliminate post-traumatic stress disorder (PTSD), or an associated symptom/metric, in a treated subject.

USPTO Abstract

This disclosure provides therapeutic methods involving administration of BNC210 to a subject in an amount effective to reduce or eliminate post-traumatic stress disorder (PTSD), or an associated symptom/metric, in a treated subject.

Drugs covered by this patent

Patent Metadata

Patent number
AU2024348342A1
Jurisdiction
AU
Classification
—
Expires
2026-04-30
Drug substance claim
No
Drug product claim
No
Assignee
Bionomics Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.